Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
122,470,452
-
Total 13F shares
-
50,826,972
-
Share change
-
+2,556,759
-
Total reported value
-
$2,056,609,533
-
Put/Call ratio
-
160%
-
Price per share
-
$40.47
-
Number of holders
-
136
-
Value change
-
+$107,109,155
-
Number of buys
-
72
-
Number of sells
-
65
Institutional Holders of Arcus Biosciences, Inc. - Common Stock (RCUS) as of Q4 2021
As of 31 Dec 2021,
Arcus Biosciences, Inc. - Common Stock (RCUS) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,826,972 shares.
The largest 10 holders included
EcoR1 Capital, LLC, BlackRock Inc., PFM Health Sciences, LP, VANGUARD GROUP INC, BVF INC/IL, FMR LLC, Alphabet Inc., STATE STREET CORP, Octagon Capital Advisors LP, and Woodline Partners LP.
This page lists
136
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.